Clinical Trial Update: Randomized Evaluation and Verification of Ventricular Enhancement [NA]

View source ↗

Summary

A randomized evaluation and verification of a ventricular enhancement system by BioVentrix for ischemic cardiomyopathy and heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Cardiomyopathy

Drugs mentioned

• Ventricular Enhancement System

Snippet

Sponsor: BioVentrix | Conditions: Ischemic Cardiomyopathy, Heart Failure | NA | Status: WITHDRAWN